Container Closure Change for Thymosilib. Container Closure Change for Thymosilib — routine update. Impacts 3 markets and 2 variations.

Change Number
CHG-2022-0047
Type
Container Closure Change
Product
Status
Pending
Owner
Nadia Petrova
Initiated
2023-03-05
Description

Container Closure Change for Thymosilib — routine update

Impacted Markets (3)
JP — JapanGB — United KingdomTR — Turkey
Impacted Modules
3.2.S3.2.P2.3.P
Linked Variations (2)
Variation #TypeApplicationStatusSubmittedApproved
TFDA-2024-0031-V231MajorTFDA-2024-0031Draft2023-12-12—
HSA-2023-0032-V232MinorHSA-2023-0032Failed2023-03-17—